Scientists have taken a first step toward improving those problematic PSA tests for prostate cancer, by mixing in some genetic information that might help tell which men really need a biopsy. The ...

Results of a new study, presented today at the National Cancer Research Institute (NCRI) Conference, show that a new prostate cancer marker could play a crucial role in helping clinicians decide on ...

Prostate cancer is the most common form of cancer among men in Western countries. Can aggressive prostate cancer eventually ...

A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive prostate cancer and personalise screening strategies.

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single ...

Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.